RedHill Biopharma (RDHL) Receivables - Net (2016 - 2025)
RedHill Biopharma (RDHL) posted quarterly Receivables - Net of $5.4 million for Q2 2025, up 449.28% year-over-year from $974000.0 in Q2 2024, and up 110.71% quarter-over-quarter from $2.5 million in Q4 2024.
RedHill Biopharma (RDHL) Receivables - Net (2016 - 2025) Analysis & Trends
RedHill Biopharma (RDHL) has reported Receivables - Net for 10 consecutive years, with $5.4 million the latest figure, recorded in Q2 2025.
- In Q2 2025, Receivables - Net rose 449.28% year-over-year to $5.4 million; the TTM figure through Jun 2025 stood at $5.4 million (up 449.28% YoY), while the FY2025 annual figure was $201000.0, down 92.08% from the prior year.
- Receivables - Net climbed to $5.4 million in Q2 2025 per RDHL's latest filing, from $2.5 million in the prior quarter.
- Across five years, Receivables - Net topped out at $36.0 million in Q3 2022 and bottomed at $974000.0 in Q2 2024.
- Historically, Receivables - Net has averaged $19.0 million across 5 years, with a median of $24.6 million in 2021.
- Annual changes were most pronounced in 2021 — Receivables - Net surged 1257.37% — and 2023, when it plunged 92.49%.
- RedHill Biopharma's Receivables - Net stood at $31.7 million in 2021, then grew by 8.98% to $34.5 million in 2022, then slumped by 92.49% to $2.6 million in 2023, then retreated by 2.01% to $2.5 million in 2024, then soared by 110.71% to $5.4 million in 2025.
- Business Quant data shows RDHL's Receivables - Net at $5.4 million in Q2 2025, $2.5 million in Q4 2024, and $974000.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - |
| 10 | RedHill Biopharma | 2.05 Bn | 2.05 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 201,000.00 |
| Dec 31, 2025 | 201,000.00 |
| Jun 30, 2025 | 5.35 Mn |
| Jun 30, 2025 | 5.35 Mn |
| Dec 31, 2024 | 2.54 Mn |
| Dec 31, 2024 | 2.54 Mn |
| Jun 30, 2024 | 974,000.00 |
| Jun 30, 2024 | 974,000.00 |
| Dec 31, 2023 | 2.59 Mn |
| Dec 31, 2023 | 2.59 Mn |
| Jun 30, 2023 | 2.90 Mn |
| Jun 30, 2023 | 2.90 Mn |
| Mar 31, 2023 | 6.85 Mn |
| Mar 31, 2023 | 6.85 Mn |
| Dec 31, 2022 | 34.52 Mn |
| Dec 31, 2022 | 34.52 Mn |
| Sep 30, 2022 | 36.01 Mn |
| Sep 30, 2022 | 36.01 Mn |
| Jun 30, 2022 | 33.76 Mn |
| Jun 30, 2022 | 33.76 Mn |